INTRODUCTION
The glomeruli, because they receive one-quarter of the cardiac output and arc perfused at the highest pressure of any capillary bed in the body, are vulnerable to injury by a number of drugs and other toxic agents. These agents may lead to damage by one oftwo basic mechanisms: 1) direct, dose-related toxic injury; 2) indirect, immunologically mediated injury, largely dose-independent. For our purposes, the simplest and most important functional indicator of glomerular injury is the appearance of proteinuria, which occurs rather promptly in most situations of direct toxic injury, but which may not appear for weeks to months in immunologically mediated processes. Of these two basic mechanisms, the second is by far the more common in clinical settings. Experimental models of each type will be described as a background to the discussion of the clinical examples presented. DIRECX TOXIC GLOMERULAR INJURY Experimental Models. Relatively rectly attacking glomeruli are in clinical use, although there are several experimental models oftoxic glomerular injury in which the mechanisms of injury have been reasonably well worked out.
Aniinonitcleoside Nephrosis. This is perhaps the best-studied model ofdirect glomerular damage, with many pathologic similarities to the clinical entities of lipoid nephrosis and focal segmental glomerulosclerosis. A single dose of the aminonucleoside of puromycin in rats or mice gives rise to a severe nephrotic syndrome (1 1,43). The proteinuna is biphasic, with an early peak at about 7 days, a decline, and then a steady riseto death at about 15 months. In the first phase, the epithelial cells show the most evident lesions, with effacement of foot processes, marked increase in phagosomes, and loss of lysosomes. There may even be areas oftotal detachment of the epithelium from the basement membrane, a feature almost never seen in other models. The basement membrane may thus come into direct contact with Bowman's capsule. There is a concomitant loss of the negatively charged heparan sulfate proteoglycans, as reflected in marked loss of staining of negatively charged sites on the basement membrane and epithelium by such stains as Alcian blue. However, somc evidence indicates that the turnover of heparan sulfate protcoglycans is actually increased
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TOXICOLOGIC PATHOLOGY (30). There is considerable debate as to whether the loss of negatively charged sites is responsible for the proteinuria, or is simply a consequence of it. Subsequently there is a progressive glomerulosclerosis, with increased basement membrane synthesis, mesangial cell proliferation, and focal segmental hyalinization (44). The picture closely resembles that seen in the hyperfiltration, renal ablation model of Brenner (9) , or spontaneously in aging rats. It has been demonstrated that the segments of mesangium ultimately destined to undergo sclerosis show an increased uptake of colloidal carbon from the outset, indicating an abnormality in mesangial uptake and processing (23).
Phorbol Myristate Acetate (PMA). This agent is known to be a potent activator of neutrophils and macrophages, resulting in the generation of large amounts of oxygen-free radicals, notably hydrogen peroxide (H202) and superoxide anion (02-). Injection of PMA into the renal artery in rats results in prompt, marked proteinuria, which is prevented by prior depletion of neutrophils but not by complement depletion (4 1). Electron microscopy reveals numerous neutrophils in the glomerular capillaries with endothelial blebbing, and focal separation from the basement membrane, as well as the expected epithelial changes accompanying proteinuria.
Other agents have been associated experimentally with direct toxic glonierular damage. In experimental animals, although not in man, adriamycin ( 5 5 ) and daunomycin consistently give rise to a nephrotic syndrome, with an appearance and course much like that for puromycin. And, although the renal effects of D-penicillamine are generally immunologically mediated, Batsford (5) has demonstrated direct glomerular toxicity in rats resulting in proteinuria.
Clinical Experience.. Clinical examples of direct glomerular toxicity to therapeutic agents are relatively limited. These examples are confined, for the most part, to isolated case reports of nephrotic syndrome occurring in the course of cytotoxic therapy with cyclophosphamide (35). In rare cases, other agents have been associated with proteinuria, such as probenecid and perchlorate therapy for thyrotoxicosis (33).
Cyclosporitt A (CyA). This agent, which is just coming into wide use in the treatment of transplant rejection, will undoubtedly be increasingly reported as a cause of direct glomerular and vascular toxicity. Its tubulointerstitial toxicity is already well recognized because it routinely gives rise to azotemia, mild proteinuria, a concentrating'defect, and often hypertension in patients with bone marrow and cardiac transplants (3,28). Experimental studies in rats have revealed only a mild tubulointerstitial nephritis, even at very large doses of CyA (47, 56), and biopsy studies have for the most part also emphasized the tubulointerstitial component and the ways in which it may be distinguished from renal allograft rejection (46). However, it is now recognized that some patients may develop symptoms that closely resemble hemolytic uremic syndrome or thrombotic thrombocytopenic purpura (3, 45, 46). On biopsy, t'he glomeruli and afferent arterioles show endothelial swelling, subendothelial accumulations of red $1 fragments and fibrin, with frank arteriolar and gfomerular thrombosis in the more severe cases ( Fig.  1) . Experimentally, administration of CyA to rabbits with classical acute serum sickness leads to a similar picture of arteriolar and glomerular thrombosis (39). The reason for this microangiopathic picture is not completely worked out, but it is known that CyA markedly reduces the synthesis of prostacyclins by the vascular endothelium (42). These compounds ordinarily discourage the aggregation of platelets and initiation of clot formation. They also act as vasodilators.
INDIRECT IhlhlUNOLOGICALLY MEDIATED
GLOMERULAR INJURY Drug-related immunologic damage to the glomeruli might theoretically occur by one of two basic mechanisms:
1) The drug itself can function either as a hapten attached to some native protein, or as a complete antigen, eliciting an antibody response. Circulating immune complexes may be deposited in the glomerulus, or alternatively, may be formed itz sitti in the glomerulus with the attachment of antigen to glomerular structures, followed by deposition of the antibody.
2) The drug may alter some somatic structure, for example DNA, so that it forms an autoantigen leading to autoantibody formation. The result may be a lupus-like syndrome, leading to secondary renal deposition and damage.
Indirect evidence indicates that each of these mechanisms is operative in different situations.
Experimental Models. A number of drugs (such as penicillamine, gold, and mercury salts), when complicated by a drug-induced glomemlopathy, routinely produce a membranous nephropathy with a nephrotic syndrome. There are two basic experimental models of membranous nephropathy, each of which has features in common with the druginduced lesions:
1) Chronic serum sickness. Daily administration of small amounts of an antigen; for example, bovine serum albumin will produce a spectrum of responses ranging from no lesions to a severe proliferative glomerulonephritis. In a certain propor-
The glomerular capillary on the right shows marked swelling of the endotheliurn, nearly occluding the lumen. These arc large, dense subendothelial deposits. The capillary on the left shows deposits adjacent to the basement membrane. There has been dissolution of the endothelium and frank thrombosis with dark tactoids of fibrin apparent. tion of animals with the appropriate level of antibody production, a . typical membranous nephropathy with abundant subepithelial deposits is produced (20). The analogy of this model to daily administration of small amounts of antigen is evident. Unfortunately, the model is not reliably reproducible in a given animal.
2) Autologous immune complex (Heymann) nephritis. Administration of an extract of whole kidney or of purified tubular brush border antigen (FXl A) leads consistently to a membranous nephropathy with a brisk nephrotic syndrome (1 3).
Intense investigation of this model has revealed a number of facts of interest. First, the complexes can form in situ in the glomerulus, with the antigen first attaching to the glomerular basement membrane or epithelial structures, and then the antibody only subsequently binding to the antigen (1 3). Preformed complexes may also bc deposited; some of these dissociate and pass through the basement membrane to reassociate there (37). Second, complex formation is charge dependent, with the most positively charged antigens localizing more readily (1 8). Third, mediation of the proteinuria is leukocyte independent, but complement dependent (1, 13). In particular, the process appears to be dependent on the membrane attack complex (MAC), C5b through C9, assembled as a functional unit (24). As its name implies, the MAC seems to work its damage in other situations by punching holes in the membrane. However, its mechanism in Heymann nephritis is not yet clarified.
Cliriical Experience. A number of drugs have been associated rather consistently with immunologically-mediated nephropathies and nephrotic syndrome: penicillamine, gold salts, mercurial agents, certain anticonvulsants (trimethadione and distraneurine), and the antihypertensive agent cap-
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TOXICOLOGIC PATHOLOGY topril(l9). These agents have the following features in common: 1) All give rise in the majority ofcases to a membranous nephropathy, usually with an associated nephrotic syndrome. However, as might bc anticipated, depending on antigen load or antibody response, the pattern may occasionally be focal, segmental or even crescentic glomerulonephritis.
2) They are characterized by a latent period, often weeks to months, before onset of the nephrotic syndrome. Aside from this, however, there is no evident relation between the duration or dosage of administration and the seventy of the nephropathy produced.
3) In general, cessation of the drug leads to clearing of the proteinuria and of the immune deposits, although captopril seems to be something of an exception to this.
4)
In none of these agents is the precise antigen or hapten responsible for the lesion completely elucidated, although there are strong candidates in some instances.
The following section includes specific information on several of the more important agents.
Peiiicillainiiie. This is the agent which most commonly gives rise to glomerulopathy. Renal side effects are present in 10-20% of cases, usually after a delay of up to 8-9 months. Usually the lesion is a membranous nephropathy, but rarely a crescentic glomerulonephritis may be seen (4, 29, 48). There is strong suspicion that the offending component, acting as a hapten, is the pcnicilloyl moiety, since antibodies may be detected in the serum of patients with the lesion (36) . It appears that this is the same offender in methicillin-mediated tubulointerstitial nephritis (8) .
Gold Preparatiotis. The incidence of proteinuria with gold preparations has been variously estimated at 1-39'0 (19) . The deposits in this lesion tend to be smaller and more segmental than in a typical membranous nephropathy. Interestingly, although gold particles can routinely be recognized in lysosomes in the proximal tubules, gold has never been identified in the glomerular subepithelial deposits, either by routine electron microscopy or by X-ray microanalysis (52, 54) . The possible parallels of this situation to Heymann nephritis are self-evident, but the tubular antigen has yet to be recognized in the deposits, either in man or in the experimental model (38) .
Mercurial Preparations. Mercurial agents have largely fallen in disuse, fortunately because of the incidence of proteinuria was as high as 16% and of nephrotic syndrome 4% with thew agents (19) . The cases of mercury-associated membranous nephropathy tend to bc more florid and have more deposits than other drug-associated membranous lesions (53) . Often they show a substantial component of interstitial inflammation and tubular atrophy. In general, they do not have as good a prognosis or respond as well to cessation of the medication as other drugrelated nephropathies (19) . As with gold, it is often possible to recognize mercury-containing inclusions in lysosomes in the proximal tubular epithelium (14) . The tendency of the process to continue despite drug stoppage and the inclusions in the tubular cytoplasm hint strongly that this disease resembles Heymann nephropathies, but this has yet to be demonstrated.
Captopril. This is a widely prescribed antihypertensive agent, a low-molecular weight polypeptide that acts as an angiotensin-converting enzyme inhibitor. It is attended by an incidence of nephrotic syndrome and membranous nephropathy (Fig. 2) on the order of one percent, if preexisting lesions are accounted for (10, 27, 50) . At first there was doubt that the association was anything other than fortuitous, but cases have now bcen reported in which pretreatment biopsy definitely ruled out any preexisting membranous lesions (49) . There is some in-Vol. 14 dication that these lesions do not respond in a reliable fashion to cessation of captopril (50) .
Drug-Indtrced Systemic Liiptis Erythematosiis.
A long and impressive list of drugs has been associated with the development of a lupus-like syndrome. Some of them only quite rarely produce this condition, while there are others with a frequency approaching one percent (34). Among the worst offenders are hydralazine, procainamide, penicillamine, various anticonvulsants (particularly trimethadione), propylthiouracil, and Aldomet. In each instance antinuclear antibodies can be demonstrated, although the specificities vary considerably. Some antibodies are directed against doublestranded n-DNA (these appear to be the most potent in generating renal lesions), while others are directed against denatured s-DNA and a variety of nucleoproteins.
Five to 209'0 of the patients taking one of the more frequently offending drugs such as hydralazinc (7) may develop antinuclear antibodies, but only a small minority of these patients will develop a lupus-like syndrome. Although pleuropulmonary involvement is more frequent (7, 34) , the drug-induced variant of lupus tends to be less severe, with fewer constitutional symptoms and less skin and renal manifestations. Among the small percentage of patients who develop lupus-like renal manifestations, the drugs hydralazine, anticonvulsants, vropylthiouracil, penicillamine, and procainamide are the most frequent causal agents (19) .
Clinically, there is proteinuria with variable hematuria, and there may be a frank nephrotic syndrome. As expected, idiopathic SLE presents a wide variety of appearances on renal biopsy, and renal biopsies from drug-related SLE also present several pictures. A membranous nephropathy, similar to that seen in other conditions, is probably the most common pattern (25, 51, 57). However, examples with mesangial increase and focal, segmental accentuation, with occasional segmental necroses (Fig. 3) , corresponding to the focal proliferative variant of lupus nephritis may also bc seen (5 1, 58, 59) . There may also be a substantial tubulointerstitial component in some cases.
The critical factor in the development of the syndrome, at least in most instances, seems to be the complexing of the drug with catabolically released DNA (21). The drug-DNA complex thus becomes the autoantigen evoking antibody production (2).
Heroin abusers develop proteinuria and frank nephrotic syndrome more frequently than the population at large. Friedman (17) has estimated that one percent or more of addicts develop nephropathy, and in our experience even this estimate seems low.
Two basic patterns of lesions develop. The first, and by far the more common, is a focal segmental glomerulosclerosis (FSG). Morphologically, the lesion resembles FSG seen in other circumstances. At the outset most glomeruli are normal by light microscopy or show only mild mesangial increase. However, as the lesion progresses (starting at the corticomedullary junction and spreading outward) the glomeruli begin to show segmental areas of glomerular capillary and mesangial sclerosis with some epithelial cell proliferation about such sclerosing segments. Often, there are large hyaline subendothelial deposits either partly or completely obliterating the capillary lumen. These deposits are located in or near the sclerotic segments and form the so-called "hyalinosis" lesion. Immunofluorescence reveals that these segments stain in a vivid, blobby fashion for IgM, C3, and often fibrinogen, Electron microscopy shows that the epithelium over the sclerosing and sclerotic segments often appears partly detached and pulled away, with the resulting cleft filled in by fibrillar, basement-membrane-like material (22).
Although these cases resemble idiopathic FSG morphologically, the experience of most clinicians Heroin-Relat ed Nepiiropath y. 42 
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A second form of heroin-related nephropathy is renal amyloidosis, seen almost exclusively in persons who "skin-pop," that -is, inject the heroin subcutaneously (26). This practice results in subcutaneous abscesses which are produced continuously and in substantial numbers, leading to a more or less permanent elevation of serum amyloid protein. This protein is an acute phase reactant. It is produced promptly by any stimulation of the inflammatory process, and returns to normal as inflammation subsides. In certain individuals, the breakdown products of this protein show a marked tendency to polymerize, leading to deposition of amyloid in various tissues. This mechanism leads to systemic amyloidosis in some patients with tuberculosis, chronic osteomyclitis, and rheumatoid arthritis, and in patients with permanent subcutaneous abscesses related to "skin-popping."
The renal lesions are similar to those seen in other forms of renal amyloidosis. There are variable vascular, interstitial, and tubular basement membrane deposits of amyloid, but in the early stages it is the glomerular deposits which take functional precedence, leading to a heavy proteinuria and nephrotic syndrome. The glomerular deposits tend to be localized first in the mesangium, leading to large acellular mesangial nodules, and only later spread out along the capillary basement membranes (Fig, 4) .
However, in some instances there may be striking transmembranous deposits arrayed in perpendicular fashion, which give the appearance of "spike" formation. These deposits resemble those found in membranous nephropathy, although in a much more patchy and irregular fashion.
Patients with heroin-related amyloidosis tend to do poorly because they refuse to give up their habit and because renal deposits of amyloid, once established, resolve very slowly, if at all (26).
GLOMERULAR LESIONS ASSOCrATED WITH
VOLATILE HYDROCARBON EXPOSURE The possible association between hydrocarbon exposure and glomerulonephritis has been the subject of considerable controversy in recent years. The issue was initially raised by Beirne and Brennan (6) who found that 6 out of 8 subjects with Goodpasture's syndrome had a history of exposure to hydrocarbon-containing solvents. Since then, a number of case rcports have appeared supporting this contention. Most of the patients have had Goodpasture's syndrome, although a group have been reported with membranous nephropathy and rarely other lesions (12) . A number of case-control studies have appeared. Almost all report a significantly greater exposure to hydrocarbons among patients with glomerulonephritis than among control groups (1 2, 16, 32, 40) . However, Churchill et a1 (1 2) have examined these studies carefully from the epidcmiologic and biostatistical points of view and have concluded that most of the studies were flawed. Two studies without methodologic flaws failed to demonstrate the hydrocarbon-glomerulonephritis association conclusively. Thus, the issue must be regarded as unresolved, although the evidence seems to point to some degree of association between the two.
Goodpasture's syndrome, the combination of pulmonary hemorrhage and glomerulonephritis due to antibodies reactive with alveolar capillary walls and glomerular basement membranes (GBM), has been the picture most frequently reported. In this condition, glomerular immunofluorescence reveals continuous, ribbon-like, linear staining of the GBM with IgG and C3 (although this latter may have a vol. 14, NO. 1, 1986 GLOMERULOPATHIES 4 3 very finely granular quality). Although staining is uniform throughout all glomeruli, light microscopy shows that lesions are at first confined to focal, segmental necrosis, with crescent formation about the necrotic segment. However, virtually all the glomeruli will show involvement by a severe, crescentic glomerulonephritis. Formerly this lesion was uniformly fatal. Nowadays the picture has been improved by various combinations of immunosuppressive therapy, dialysis, and transplantation. The proposed pathogeqesis for Goodpasture's syndrome is primary damage to the alveolar basement membrane by inhalation of the volatile hydrocarbons. T h e altered alveolar basement membrane would then elicit autoantibodies which attack both the alveolus and cross react with glomerular basement membrane (19) . There is some experimental evidence to support this theory (3 l), but the issue is not settled.
In the cases of membranous nephropathy, Ehrenreich et a1 (15) have proposed a pathogenesis in which the hydrocarbons damage tubular epithelium with release of endogenous tubular antigens. These antigens would then elicit autoantibody production, with development of a membranous nephropathy, as in the Heymann autologous immune complex model.
